-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Coeptis Therapeutics Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q2 2024.
- Coeptis Therapeutics Holdings, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.83M, a 23.3% increase year-over-year.
- Coeptis Therapeutics Holdings, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$17M, a 9.92% increase year-over-year.
- Coeptis Therapeutics Holdings, Inc. annual Operating Income (Loss) for 2023 was -$21.5M, a 37.2% increase from 2022.
- Coeptis Therapeutics Holdings, Inc. annual Operating Income (Loss) for 2022 was -$34.2M, a 143% decline from 2021.
- Coeptis Therapeutics Holdings, Inc. annual Operating Income (Loss) for 2021 was -$14M, a 20426% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)